Arrowhead Pharmaceuticals(ARWR) - 2025 Q4 - Earnings Call Transcript

Arrowhead Pharmaceuticals (NasdaqGS:ARWR) Q4 2025 Earnings Call November 25, 2025 04:30 PM ET Company ParticipantsVince Anzalone - VP of Investor RelationsAndy Davis - SVP and Head of Global Cardiometabolic FranchiseChris Anzalone - President and CEOBruce Given - Chief Medical OfficerAndrea Newkirk - Vice President of Biotechnology Equity ResearchDan Apel - CFOMike Ulz - Executive Director of Biotechnology Equity ResearchJames Hamilton - Chief Medical Officer and Head of R&DConference Call ParticipantsPrakh ...